| Authors: |
Buchsbaum JC; National Cancer Institute, Bethesda, Maryland 20892., Jaffray DA; The University of Texas, MD Anderson Cancer Center, Houston, Texas 77030., Ba D; Harvard University, Cambridge, Massachusetts 02138., Borkon LL; Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21701., Chalk C; U.S. Department of Energy, Boyds, Maryland, 20841., Chung C; The University of Texas, MD Anderson Cancer Center, Houston, Texas 77030., Coleman MA; Lawrence Livermore National Laboratory, Livermore, California 94550., Coleman CN; National Cancer Institute, Bethesda, Maryland 20892., Diehn M; Stanford Medicine, Stanford, California 94305., Droegemeier KK; University of Oklahoma, Norman, Oklahoma 73072., Enderling H; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612., Espey MG; National Cancer Institute, Bethesda, Maryland 20892., Greenspan EJ; National Cancer Institute, Bethesda, Maryland 20892., Hartshorn CM; National Cancer Institute, Bethesda, Maryland 20892., Hoang T; U.S. Department of Energy, Washington, DC 20585., Hsiao HT; American Society for Radiation Oncology (ASTRO), Arlington, Virginia 22202., Keppel C; Jefferson Lab, Newport News, Virginia 23606., Moore NW; Sandia National Laboratories, Albuquerque, New Mexico 87123., Prior F; University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205., Stahlberg EA; Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21701., Tourassi G; Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830., Willcox KE; The University of Texas at Austin, Austin, Texas 78712. |
